Called Convidecia, the inoculation includes just one shot, like the Janssen vaccine. Anvisa now has seven business days to issue a reply, which may be extended if the watchdog needs further clarifications or new information regarding the consortium of companies charged with the offer of the inoculation in Brazil.
The decision for the emergency use of the two vaccines was made unanimously. All five Anvisa directors voted in favor of Director Meiruze Freitas’s report.
The selection of documents in the request and the proposal for the emergency use the laboratory plans to make has been initiated. Anvisa’s goal is to analyze the emergency use in up to ten days
According to Brazil’s sanitary regulator, no laboratory has yet filed a request for use, even after the watchdog published guidelines for applications.
Português 
Español 
